Trial Profile
Detecting an Early Response to Donepezil With Measures of Visual Attention
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Feb 2021
Price :
$35
*
At a glance
- Drugs Donepezil (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
- 13 Jan 2021 Status changed from active, no longer recruiting to completed.
- 12 Feb 2020 Planned End Date changed from 31 Dec 2019 to 31 Dec 2020.
- 18 Oct 2019 Planned End Date changed from 31 Jul 2019 to 31 Dec 2019.